Cannvas MedTech (CSE:MTEC), a leader in digital cannabis education and leading business technology company, is pleased to announce the addition of the Cannabis and Science module to the Cannvas.Me education platform, where those curious about the scientific complexities of cannabis can explore and learn about strains, the chemical makeup of the plant, and how the active compounds in cannabis make it a potential benefit to a healthy lifestyle.

“I have always been interested in the science of cannabis and how the different strains produce different effects depending how they are used and who uses them,” said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. “Our Cannabis & Science module takes a closer look into this miraculous plant to discover its unique properties. There are many documented benefits of using medical cannabis for certain illnesses, and we want to explore and discover the science behind those therapeutic benefits.”


The Cannvas.Me Cannabis & Science module is for active and potential cannabis users interested in learning more about the science of the plant and how it impacts the human endocannabinoid system. Whether users have questions about cannabinoids, endocannabinoids, or phytocannabinoids, or are curious about the differences between tetrahydrocannabinol, cannabidiol or terpenes, the Cannabis & Science module explores all aspects of the cannabis plant and how it interacts with the human body. As with all Cannvas.Me modules, the Cannabis & Science module is overseen by the Cannvas.Me Medical Advisory Board and Educational Advisory Panel to ensure all information presented is relevant, accurate and timely.

Canada is leading the transformation of the cannabis world through legalization and through the emergence of an influential and powerful industry. Cannvas is committed to bring high quality education and information to Canada and around the world to ensure proper use and promote the benefits of cannabis. Additional relevant modules and tools will be added to the platform as they become available.

Cannvas.Me is an unbiased educational resource for medicinal and adult-use cannabis users. It is a comprehensive solution for the global cannabis community offering innovative tools and physician-backed content to all audiences wishing to learn about health care through cannabis. The education platform utilizes machine-learning algorithms and artificial intelligence (AI) to contextualize and adapt as users navigate the website, to ensure a best-in-class experience for all using the most accurate and up-to-date information.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted onwww.sedar.com.

For further information: www.cannvasmedtech.com, Media Inquiries: media@cannvasmedtech.com, Investor Relations: ir@cannvasmedtech.com, 1-800-489-0116

Related Links

https://cannvasmedtech.com

Click here to connect with Cannvas MedTech (CSE:MTEC) for an Investor Presentation. 

Source: www.newswire.ca

Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States today announced the appointment of Marcum LLP (“Marcum”) as its independent registered public accounting firm, effective July 5, 2021 . Marcum was appointed following the resignation of MNP LLP (“MNP”) as the Company’s independent registered public accounting firm effective July 5, 2021 .

“We would like to thank MNP for their guidance and expertise over the past two years and we look forward to working with Marcum as the Company’s new independent registered public accounting firm,” stated Chief Financial Officer, Alex D’Amico.

Keep reading... Show less

Cannabis-infused beverages are not a new product concept, but this summer Canadian drink makers hope consumers will discover them for the first time.

Recreational cannabis beverages have beguiled Canadian producers through different avenues, and many continue to make investments. The promise of these drinks lies in the potential of a more welcoming option for new consumers who may be out of their depth with rolled-up dried flower.

Keep reading... Show less

In the news release, BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years, issued 07-Jul-2021 by BioHarvest Sciences Inc. over PR Newswire, we are advised by the company that an incorrect version of the release was issued inadvertently. The complete, corrected release follows:

BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years

Keep reading... Show less

Trulieve is the first medical cannabis operator to start planting in the state

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today that it commenced operations in West Virginia . The Company has begun cultivation at their 100,000 square foot size facility in Huntington, West Virginia .

Keep reading... Show less

– The Company demonstrates the efficiency and reliability of its BioFarming technology by reducing production cycle time for Cannabis from 14-23 weeks to 3-4 weeks.

– The Company’s BioFarming technology will allow the Company to harvest 13-17 cycles per year versus 2-4 cycles per year for conventional Cannabis agriculture.

Keep reading... Show less